FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV
Nirsevimab is the first shot approved by the FDA to protect all infants against RSV regardless of whether they are healthy or have a medical condition.
![](https://kbin.life/media/cache/resolve/entry_thumb/f8/b7/f8b712c7f30c56f8072c163b9daa24e1f5089bb7aad10376758c89a3bec466c9.jpg)
There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.
Accounts which solely post advertisements, or persistently post them may be terminated.
Nirsevimab is the first shot approved by the FDA to protect all infants against RSV regardless of whether they are healthy or have a medical condition.